|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 760.70 BDT | -0.48% |
|
+0.89% | +7.44% |
| Market Cap | 1.82B 14.73M 12.89M 11.88M 11M 20.87M 1.41B 21.22M 142M 55.79M 690M 55.3M 54.11M 2.39B | P/E 2024 |
189x | P/E 2025 | 369x |
|---|---|---|---|---|---|
| Enterprise Value | 2.32B 18.84M 16.48M 15.2M 14.06M 26.69M 1.8B 27.14M 182M 71.34M 883M 70.72M 69.19M 3.06B | EV / Sales 2024 |
10.4x | EV / Sales 2025 | 10.7x |
| Free-Float |
22.75% | Yield 2024 |
0.13% | Yield 2025 | 0.12% |
| 1 day | -0.48% | ||
| 1 week | +0.89% | ||
| Current month | +0.56% | ||
| 1 month | -2.29% | ||
| 3 months | +0.71% | ||
| 6 months | +6.35% | ||
| Current year | +7.44% |
| 1 week | 751.1 |  | 780 |
| 1 month | 750 | | 782 |
| Current year | 689 | | 821 |
| 1 year | 681 | | 929 |
| 3 years | 511 | | 1,302.3 |
| 5 years | 375.3 | | 1,302.3 |
| 10 years | 285.6 | | 1,302.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Director of Finance/CFO | - | - | |
| Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | - | |
| Director/Board Member | - | - | |
Nurjehan Hudda
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.48% | +0.89% | -5.11% | +45.78% | 14.81M | |
| -0.17% | +1.61% | +16.42% | +85.22% | 48.73B | |
| +1.04% | -1.02% | +69.47% | +115.88% | 35.82B | |
| -0.13% | -1.29% | -2.60% | +41.58% | 12.2B | |
| -0.71% | +0.89% | +18.28% | +97.87% | 12.11B | |
| +0.19% | +1.75% | +34.02% | +123.93% | 9.11B | |
| -0.86% | +0.37% | +52.61% | -3.54% | 7.09B | |
| +0.83% | -0.74% | +17.59% | +44.91% | 7B | |
| +0.69% | +3.25% | +19.90% | +243.91% | 6.7B | |
| -2.19% | -3.38% | -22.26% | +7.68% | 5.78B | |
| Average | -0.18% | -0.18% | +19.83% | +80.32% | 14.46B | |
| Weighted average by Cap. | +0.08% | +0.29% | +29.67% | +90.58% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 219M 1.78M 1.56M 1.44M 1.33M 2.52M 170M 2.56M 17.19M 6.74M 83.4M 6.68M 6.54M 289M | 231M 1.87M 1.64M 1.51M 1.4M 2.65M 179M 2.69M 18.07M 7.08M 87.68M 7.02M 6.87M 304M |
| Net income | 9.68M 78.57K 68.73K 63.38K 58.64K 111K 7.5M 113K 759K 298K 3.68M 295K 289K 12.76M | 5.31M 43.08K 37.68K 34.75K 32.15K 61.03K 4.11M 62.05K 416K 163K 2.02M 162K 158K 6.99M |
| Net Debt | 445M 3.61M 3.16M 2.91M 2.69M 5.11M 344M 5.2M 34.85M 13.66M 169M 13.54M 13.25M 586M | 506M 4.11M 3.59M 3.31M 3.07M 5.82M 392M 5.92M 39.69M 15.56M 193M 15.42M 15.09M 667M |
Employees
474
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/07/26 | BDT 760.70 | -0.48% | 1,544 |
| 08/07/26 | BDT 764.40 | -1.76% | 1,607 |
| 07/07/26 | BDT 778.10 | +1.83% | 2,009 |
| 06/07/26 | BDT 764.10 | +1.33% | 1,004 |
| 05/07/26 | BDT 754.10 | +0.01% | 2,093 |
- Stock Market
- Stocks
- AMBEEPHA Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
